Lee Silverman Voice Treatment Versus Standard Speech Therapy Versus Control in Hypophonia Rehabilitation in MS
Multiple Sclerosis

About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring Voice Disorders, Speech and language therapy, Lee Silverman voice treatment
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Multiple Sclerosis according with McDonald's criteria;
- absence of relaps in the last month;
- Mini Mental State Examination (MMSE) > 21 score for a better understanding and adherence to the execution of the proposed exercises;
- hypophonia (conversation < 60 dB SPL- distance was kept equal at about 15 cm);
- ability to understand the aims of the study and acceptance to sign an informed consent;
- acceptance of the intensity of the treatment;
- ability to understand the Italian language.
Exclusion Criteria:
- Presence of other neurological disorders;
- visual/hearing impairments hindering the rehabilitation program;
- clinical history of laryngeal cancer, chemotherapy, radiotherapy, head and neck trauma or endotracheal intubation;
- relapse or sudden changes in their MS symptoms within the previous 3 months.
Sites / Locations
- Fondazione Don Gnocchi IrccsRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Lee Silverman Voice Therapy
Conventional Treatment
LSVT LOUD® is a therapy program which requires four sessions per week for 4 weeks by a speech and language therapists with a certification in Lee Silverman Voice Therapy. Each session lasted 50-60 min.
The content and dose of standard SLT is poorly defined within the published literature. For this reason, the standard therapy intervention will encompass all SLT techniques that are not LSVT®. Treatment will be individualized and may include any of the following: exercises targeting respiration, phonation, articulation, behavioral strategies to reduce prosodic abnormality